Abstract
OBJECTIVE: Pseudocatalase/superoxide dismutase (PSD) is a topical gel considered having therapeutic effects in vitiligo. This study was designed to evaluate the efficacy of this combination in vitiligo. METHODS: This was a pilot randomized, double-blind, placebo-controlled trial on 46 symmetrical vitiligo lesions of limbs in 23 patients referring to dermatology clinics, Isfahan, Iran in 2010. Patients were received this formula or placebo gels for the right and left lesions. Lesion area and degree of pigmentation were assessed at baseline, 2, 4, and 6 months. FINDINGS: There were no significant changes in lesion area and perifollicular pigmentation in each group (P > 0.05). CONCLUSION: The results indicated no significant therapeutic effect for PSD in vitiligo.